A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
about
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infectionPrevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesA national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan.The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controlsEpidemiology of hepatitis C virus infection among injecting drug users in Australia.Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.Syringe availability as HIV prevention: a review of modalities.Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.Epidemiology and control of hepatitis B infection: a perspective from the Philippines, AsiaHepatitis C: an epidemiological review.Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review.Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitionsMolecular and contextual markers of hepatitis C virus and drug abuse.Updating the infection risk reduction hierarchy: preventing transition into injection.Non-injection drug use and Hepatitis C Virus: a systematic review.Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi ArabiaCommon genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.Factors associated with adolescent initiation of injection drug use.Case-reporting of acute hepatitis B and C among injection drug users.The association of complex liver disorders with HBV genotypes prevalent in PakistanIncidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States.Limited uptake of hepatitis C treatment among injection drug usersMeta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug usersDifferences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the NetherlandsModelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.Harm reduction in the USA: the research perspective and an archive to David Purchase.Injection risk behavior among women syringe exchangers in San Francisco.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?Hepatitis C is more severe in drug users with human immunodeficiency virus infection.Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.
P2860
Q28361460-3884D853-2A51-4137-8192-3406E07DEAFAQ28768135-8E8D7524-F328-4F9F-A6AD-0F6D1DFF8E7BQ30226978-05AD2558-11AF-4305-957A-DF192569B1F4Q31152033-EABBBF32-DD0A-4E23-808E-25038302155AQ33256564-9700B240-74C1-4EB9-AEF7-317DDAE1BDD3Q33397169-B324CF0E-ACCF-4E8F-AB37-6962515B850CQ33534850-F38DDC6E-9ADA-4497-98B5-0232C58BD9ABQ33704770-02851DBF-410E-4046-88D2-869BDB4A6246Q33825988-38788F15-BC63-4378-81DE-298444E584D9Q34025172-38851FA5-F9B9-4CF1-9F70-7F7E6AD8B93DQ34260555-3C4F7E64-156D-4E2C-8EF6-F9B8DBE1125EQ34442028-FDD091C9-EED5-444E-875D-4031FC5AB63EQ34551348-AA5AFB6F-7E00-446E-B010-530AB28C4508Q34637206-68F5407E-FEE4-42DF-8515-9F84B457780CQ35404956-9FBBF30A-8348-4BF1-A73D-CC84C1729BA5Q35660841-D79E8716-E985-4A8E-A987-0892D2CD3C6EQ35718883-6371754C-7388-4EBD-A234-893FAE4FAF14Q35844048-66161437-5F88-4926-99A0-28964C513DF4Q35856209-177AD2A0-A22D-4B12-8664-E4EAA0187DB9Q35874884-B7CDF172-6B39-4A25-A22C-E00279C3C0F4Q35879913-0ACA2636-372C-4290-8FF2-E9C0CD98DC4CQ36274796-1BFC00AA-F6DA-47CE-9C60-CD87A56A69A7Q36402124-60AF1696-9ACE-4D98-8BEF-7E2609DC5F1DQ36548225-92D7D984-E64C-4651-AB8E-BEC268D87651Q36761395-4DBA5F05-16E2-4B58-869F-FB5BC0374618Q37238205-F97D6BC1-C436-437B-A067-244DD41AA45CQ37306146-227D291F-C3F0-410D-B277-196C017DF78BQ37349751-F08AC932-20CE-4795-8299-5652683C8D3CQ37429961-C97EE303-22C9-407E-8B3A-C5B6E83CB002Q37588133-8280717B-0E7A-475B-A3F0-3B454B477217Q39559479-98336B2E-42B5-4DDF-81F4-759E6E052833Q39679908-984AB321-232E-4D12-AA9C-0BCE517AB666Q42338244-95F1AC71-95EE-4208-91F3-31C82797ED1AQ42671943-DD23055D-1E48-4D6E-9E37-F3FB3A80913BQ42720607-E8E232F0-0A3B-4AC0-A28E-C27F5F8A4971Q43040032-E0B1FCB0-10F8-4C84-833E-DC2E62A3FA2BQ43988798-41321ADD-E9DF-4954-ABC8-FD64EC82106DQ45353717-E1EFCD7F-889A-49A5-9A4A-74D673C7535CQ45741645-D07CD8B5-7590-434A-90D7-F38C216AAB4AQ51784174-766213D9-2E1A-452F-AAB7-B42655E42D3F
P2860
A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A longitudinal study on the in ...... among drug users in Amsterdam.
@en
A longitudinal study on the in ...... among drug users in Amsterdam.
@nl
type
label
A longitudinal study on the in ...... among drug users in Amsterdam.
@en
A longitudinal study on the in ...... among drug users in Amsterdam.
@nl
prefLabel
A longitudinal study on the in ...... among drug users in Amsterdam.
@en
A longitudinal study on the in ...... among drug users in Amsterdam.
@nl
P2093
P2860
P356
P1476
A longitudinal study on the in ...... among drug users in Amsterdam.
@en
P2093
E J Van Ameijden
G H Mientjes
J A Van den Hoek
R A Coutinho
P2860
P2888
P304
P356
10.1007/BF00146260
P577
1993-05-01T00:00:00Z